Predicting Breast Cancer Response To Chemotherapy

[News]

Chemotherapy is a major first line defense against breast cancer. However a patient's response is often variable and unpredictable. A study published in BioMed Central's open access journal BMC Medical Genomics shows that 'gene expression signatures' for TOP2A and β-tubulin can be used to predict the outcome of chemotherapy...

More... (http://www.medicalnewstoday.com/releases/245270.php)